Emily Winslow
@EmilyWinslow4
Followers
1K
Following
6K
Media
46
Statuses
721
Medstar HPB Surgeon, Patient Experience Advocate, DC transplant, Clinical outcomes researcher, TN Vol/WI Badger, and wife/mother of 2. “My opinions are mine 😀”
Washington, DC
Joined October 2015
Had a great time on the hill meeting with lawmakers about health equity, access to cancer screening, @StopTheBleed & more with @SSATNews & @AmCollSurgeons Thankful for @GUMedicine’s proximity to Congress & the opportunity to advocate for our patients
0
1
7
🌟 #ArticleOfTheWeek 🌟 "Survival disparities in rural versus urban patients with pancreatic neuroendocrine tumor" by Drs. @Muhammadbmirza @PaulaSmithMDPhD, @mary_dillhoff, @FlavioRochaMD, @EmilyWinslow4, @skmaithel. 👀 https://t.co/vnLC0N46l8 📚 @AmJSurgery
0
6
17
Read about how we use CODA to 3D print pancreas microanatomy from serial histological sections, out today in Advanced Materials Technologies. Big thanks to the Johns Hopkins WSE manufacturing team who helped us with the printing 🤗 https://t.co/wZrkN5liX1
4
11
61
Heated discussion on liver transplant for ICC, IO therapy in HCC with different etiology, 2nd line HCC design. Fun session👍.
Continuing our morning with a very interactive discussion featuring our HCC panel. So many good questions! #DAVABermudaGI @docamitgs @Amitmahipal79 @RuthHe12 @nicole_rich8 @pgholam @MaenAbdelrahim
0
2
5
Completed another robotic donor right hepatectomy with @BenSamstein. This time we invited @JHawksworthMD to maximize our 🤖LD experience on both campuses. 👉 https://t.co/wL9GLYyVe9 (different case) @WCMSurgery @ColumbiaSurgery
@ILLS_LAPLIVER @ASTSChimera
3
3
29
🚨First registry-linked collaborative RCT using NSQIP @AHPBA @AmCollSurgeons ⭐️Pip-taz for antibioprophylaxis in whipple👉🏻⬇️ 30-day SSI in RCT ⭐️New standard of care & new way to run multi-centre trials 👏🏻Congrats everyone! @MichaelDAngeli2
https://t.co/EvtO38OWJv
jamanetwork.com
This phase 3 randomized clinical trial examines the effect of broad-spectrum perioperative antimicrobial prophylaxis on postoperative surgical site infection incidence compared with standard care...
Study findings support the use of piperacillin-tazobactam as perioperative antimicrobial prophylaxis for open pancreatoduodenectomy. https://t.co/vI0fBMTas5
1
19
49
More content with our @UofTSurgery team on day 1 of #SSO2023 tomorrow Talk assessment and management of older adults for #HPBSurgery in #SSOHUB with @HalletJulie and panelists @EmilyWinslow4 @aarringtonmd1 & Kamran Idrees 🗓4:45PM in HUB Theater @_CSSO @SocSurgOnc
0
5
21
$$$ matter! I challenge you to find any surgical society with higher R0I than @SSATNews. Active annual dues are only $155; trainees $20! Meeting registration for full active members is only $210 with early bird (ENDS TODAY) & $310 after ... https://t.co/YCOPw8MmS6
0
6
27
#HAI consortium surgeons at #AHPBA2023 | together with medical oncology colleagues, we are working to advance the field and define the role of HAI for #CRLM and intrahepatic cholangio. Q: How? A: Modern-day RCTs. Coming soon to a pump center near you. @eaonc @colontown @curecc
7
18
96
Setting the standards 📐 of common bile duct and pancreatic duct 🌱 CBD up to 8 mm < 65 y/o and up to 11 mm in ≥65 y/o 🍡 PD diameters up to 3 mm in <65 y/o and up to 4 mm in ≥65 y/o Landmark open access @Gut_BMJ paper 👏 kudos to authors ! 👉 https://t.co/hGEkfeVeRc
2
86
236
Nice collaboration with Dr. Jill Smith: repurpose a Cholecystokinin receptor antagonist to modify the tumor microenvironment by increasing CD8 T cells and decreasing fibrosis in HCC.
This week we highlighted a paper coauthored by Ruesch Center, @gumedcenter, and @LombardiCancer researchers including, Narayan Shivapurkar, @RuthHe12, and Jill P. Smith et al in @IJMS_MDPI. View the full tailored weekly GI Cancer publication output via: https://t.co/17abkAITVD.
0
2
5
Great day attending and presenting at the MedStar Pancreatobiliary diseases conference! @MedStarGUH @MedStarHealth @RueschCenter @EmilyWinslow4 @DrRCJha @ReetuMukherjiMD @DrWalidChalhoub @RuthHe12
2
6
27
Congratulations to Dr. Douglas B. Evans for receiving the 2022 Luminary Award for GI Cancer, presented by @RueschCenter and @OncLive, which recognizes individuals who have made transformative strides in the lives of patients with GI cancers. Learn more: https://t.co/8J0ILa3unL
5
9
81
📣 Special pub alert!📣 Why special?🤷🏻♀️ 👩🏼⚕️Most meaningful piece to write 👩🏻⚕️Ability to showcase strides made 👩🏾⚕️Platform to note remaining disparities 👩🏿⚕️Selected pub date - Feb 3rd!!! Thank you @AmJGastro! #IamBlackwell #NWPD
#NationalWomenPhysiciansDay
https://t.co/dST9Danruy
3
36
118
Congratulations to cardiothoracic surgeon Thomas E. MacGillivray, MD, from MedStar Health, on being elected 2023-24 President of The Society of Thoracic Surgeons. An STS member since 2003, he has served the Society in various leadership roles. https://t.co/BVYNbXD0lL
1
8
87
🔥Excellent news: Pivotal phase III IMbrave050 study is positive: The first positive adjuvant trial in #HCC🔥 👉Atezolizumab + Avastin improves RFS in pts at high risk of recurrence following surgery @myESMO @OncoAlert @EASLedu #livertwitter
0
70
165
There’s still time to register! Join us tonight to discuss all things HCC & trials with a ⭐️ panel of experts 👇🏻
Join @HalletJulie, @AEjaz85, @AdamYopp, @EmilyWinslow4, @graokane and @MarkYarchoan tonight to discuss recent, ongoing, and upcoming trials for hepatocellular carcinoma. Register at https://t.co/MhZ8pLyfVf.
#HCC
0
3
5
🙌🏾 🗞️Our #ctDNA🩸🧬paper in the #JITCTop10! MSI⬆️ #PancreasCancer …median PFS/OS NOT REACHED …among the 9 patients treated with ICI, 7/9 were alive at the time of data cut-off 1 who went for surgery➡️pathCR! #JITC #PANCSM @jitcancer Top🔟 @sitcancer @OncoAlert #OpenAccess
Countdown to 2023: #JITCTop10 - Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer https://t.co/ieDgJ6XaCD
@pashtoonkasi @doctorC369
4
30
111